The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fairman Jeff since 2020.
This trader's CIK number is 1813800.
At the time of last reporting, Fairman Jeff was the VP, Research of Vaxcyte, Inc.. (stock ticker symbol PCVX).
Also see all insider trading activities at Vaxcyte, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | PCVX | 0 | $0 | 50,000 | $1,421,730 | 4,469 | $7,999 |
| 2021 | PCVX | 0 | $0 | 42,750 | $1,032,324 | 45,543 | $56,581 |
| 2020 | PCVX | 0 | $0 | 0 | $0 | 740 | $1,324 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-10-26 | PCVX | Sale | 10,000 | 40.00 | 400,000 |
| 2022-10-11 | PCVX | Sale | 5,000 | 25.50 | 127,500 |
| 2022-08-04 | PCVX | Sale | 10,000 | 25.50 | 255,000 |
| 2022-08-05 | PCVX | Sale | 5,000 | 25.70 | 128,510 |
| 2022-05-20 | PCVX | Sale | 4,112 | 25.50 | 104,856 |
| 2022-05-05 | PCVX | Sale | 888 | 25.80 | 22,914 |
| 2022-04-05 | PCVX | Sale | 5,000 | 25.59 | 127,950 |
| 2022-03-11 | PCVX | Sale | 10,000 | 25.50 | 255,000 |
| 2021-12-20 | PCVX | Option Ex | 4,469 | 1.79 | 7,999 |
| 2021-12-27 | PCVX | Option Ex | 4,750 | 1.79 | 8,502 |
| 2021-12-27 | PCVX | Sale | 4,750 | 23.83 | 113,192 |
| 2021-12-16 | PCVX | Option Ex | 4,619 | 1.79 | 8,268 |
| 2021-12-16 | PCVX | Sale | 4,619 | 22.50 | 103,927 |
| 2021-12-09 | PCVX | Sale | 131 | 22.50 | 2,947 |
| 2021-12-09 | PCVX | Option Ex | 131 | 1.79 | 234 |
| 2021-10-26 | PCVX | Option Ex | 4,750 | 1.79 | 8,502 |
| 2021-10-26 | PCVX | Sale | 4,750 | 22.69 | 107,777 |
| 2021-09-27 | PCVX | Option Ex | 4,750 | 1.79 | 8,502 |
| 2021-09-27 | PCVX | Sale | 4,750 | 26.32 | 124,996 |
| 2021-08-26 | PCVX | Option Ex | 4,750 | 1.79 | 8,502 |
| 2021-08-26 | PCVX | Sale | 4,750 | 25.20 | 119,700 |
| 2021-07-26 | PCVX | Option Ex | 4,750 | 1.79 | 8,502 |
| 2021-07-26 | PCVX | Sale | 4,750 | 22.70 | 107,825 |
| 2021-04-22 | PCVX | Option Ex | 2,793 | 1.79 | 4,999 |
| 2021-03-26 | PCVX | Option Ex | 4,750 | .04 | 190 |
| 2021-03-26 | PCVX | Sale | 4,750 | 24.06 | 114,285 |
| 2021-02-26 | PCVX | Option Ex | 4,750 | .04 | 190 |
| 2021-02-26 | PCVX | Sale | 4,750 | 24.47 | 116,218 |
| 2021-01-26 | PCVX | Option Ex | 4,750 | .04 | 190 |
| 2021-01-26 | PCVX | Sale | 4,750 | 25.57 | 121,457 |
| 2020-12-29 | PCVX | Option Ex | 740 | 1.79 | 1,324 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fairman Jeff (VP, Research of Vaxcyte, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.